Literature DB >> 19299915

Regulation of expression of matrix metalloproteinase-9 by JNK in Raw 264.7 cells: presence of inhibitory factor(s) suppressing MMP-9 induction in serum and conditioned media.

Yun Song Lee1, Huong Thi Lan Tran, Quang Van Ta.   

Abstract

Matrix metalloproteinase-9 (MMP-9) secreted from macrophages plays an important role in tissue destruction and inflammation through degradation of matrix proteins and proteolytic activation of cytokines/chemokines. Whereas the MEK-ERK and PI3K- Akt pathways up-regulate MMP-9 expression, regulation of MMP-9 by JNK remains controversial. Presently, we aimed to determine the role of JNK in MMP-9 regulation in Raw 264.7 cells. Inhibition of JNK by the JNK inhibitor SP600125 induced MMP-9 in the absence of serum and suppressed the expression of TNF-alpha, IL-6 and cyclooxygenase-2 in LPS-treated Raw 264.7 cells. In a knockdown experiment with small interfering RNA, suppression of JNK1 induced MMP-9 expression. Interestingly, mouse serum suppressed SP600125- mediated MMP-9 induction, similar to IFN-gamma. However, the inhibitory activity of mouse serum was not affected by pyridone 6, which inhibits Janus kinase downstream to IFN-gamma. In addition to mouse serum, conditioned media of Raw 264.7 cells contained the inhibitory factor(s) larger than 10 kDa, which suppressed SP600125- or LPS-induced MMP-9 expression. Taken together, these data suggest that JNK1 suppresses MMP-9 expression in the absence of serum. In addition, the inhibitory factor(s) present in serum or secreted from macrophages may negatively control MMP-9 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299915      PMCID: PMC2679232          DOI: 10.3858/emm.2009.41.4.029

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  39 in total

1.  Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.

Authors:  D L Crowe; K J Tsang; B Shemirani
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway.

Authors:  J C-H Cheng; C H Chou; M L Kuo; C-Y Hsieh
Journal:  Oncogene       Date:  2006-05-29       Impact factor: 9.867

Review 3.  Gelatinase B functions as regulator and effector in leukocyte biology.

Authors:  G Opdenakker; P E Van den Steen; B Dubois; I Nelissen; E Van Coillie; S Masure; P Proost; J Van Damme
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

4.  Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3.

Authors:  Arjen B Blom; Peter L van Lent; Sten Libregts; Astrid E Holthuysen; Peter M van der Kraan; Nico van Rooijen; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2007-01

5.  An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression.

Authors:  M Shin; C Yan; D Boyd
Journal:  Biochim Biophys Acta       Date:  2002-05-08

6.  A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines.

Authors:  T Matsuguchi; T Musikacharoen; T R Johnson; A S Kraft; Y Yoshikai
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

7.  TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.

Authors:  Shuping Zhong; Jody Fromm; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

8.  Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes.

Authors:  Ken Arai; Sun-Ryung Lee; Eng H Lo
Journal:  Glia       Date:  2003-09       Impact factor: 7.452

Review 9.  Matrix metalloproteinase-9 in lung remodeling.

Authors:  Jeffrey J Atkinson; Robert M Senior
Journal:  Am J Respir Cell Mol Biol       Date:  2003-01       Impact factor: 6.914

10.  Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways.

Authors:  E Genersch; K Hayess; Y Neuenfeld; H Haller
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

View more
  17 in total

1.  Inhibitory Effects of Polydatin on Lipopolysaccharide-Stimulated RAW 264.7 Cells.

Authors:  Ting Lou; Wenjiao Jiang; Danhua Xu; Tong Chen; Yeliu Fu
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

2.  Falcarindiol inhibits LPS-induced inflammation via attenuating MAPK and JAK-STAT signaling pathways in murine macrophage RAW 264.7 cells.

Authors:  Thamizhiniyan Venkatesan; Young-Woong Choi; Jennifer Lee; Young-Kyoon Kim
Journal:  Mol Cell Biochem       Date:  2018-01-24       Impact factor: 3.396

3.  Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration.

Authors:  Marta Portela; Varun Venkataramani; Natasha Fahey-Lozano; Esther Seco; Maria Losada-Perez; Frank Winkler; Sergio Casas-Tintó
Journal:  PLoS Biol       Date:  2019-12-17       Impact factor: 8.029

4.  Direct Loading of iTEP-Delivered CTL Epitope onto MHC Class I Complexes on the Dendritic Cell Surface.

Authors:  Shuyun Dong; Peng Wang; Peng Zhao; Mingnan Chen
Journal:  Mol Pharm       Date:  2017-08-28       Impact factor: 4.939

5.  The novel function of advanced glycation end products in regulation of MMP-9 production.

Authors:  Fan Zhang; Greg Banker; Xiaodong Liu; Pasithorn A Suwanabol; Justin Lengfeld; Dai Yamanouchi; K Craig Kent; Bo Liu
Journal:  J Surg Res       Date:  2010-05-11       Impact factor: 2.192

6.  Expression and regulation of HIF-1alpha in macrophages under inflammatory conditions; significant reduction of VEGF by CaMKII inhibitor.

Authors:  Johanna Westra; Elisabeth Brouwer; Ingrid A M van Roosmalen; Berber Doornbos-van der Meer; Miek A van Leeuwen; Marcel D Posthumus; Cees G M Kallenberg
Journal:  BMC Musculoskelet Disord       Date:  2010-03-30       Impact factor: 2.362

Review 7.  How miRs and mRNA deadenylases could post-transcriptionally regulate expression of tumor-promoting protein PLD.

Authors:  Julian Gomez-Cambronero; Kristen Fite; Taylor E Miller
Journal:  Adv Biol Regul       Date:  2017-08-24

8.  Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(-/-) mice.

Authors:  Junwen Chen; Jiatian Cao; Lu Fang; Bo Liu; Qing Zhou; Yinggang Sun; Yue Wang; Yigang Li; Shu Meng
Journal:  J Transl Med       Date:  2014-11-26       Impact factor: 5.531

9.  NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells.

Authors:  Xinxin Tie; Sheng Han; Lingxuan Meng; Yunjie Wang; Anhua Wu
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

10.  A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 Axis.

Authors:  Yannick van Sleen; William F Jiemy; Sarah Pringle; Kornelis S M van der Geest; Wayel H Abdulahad; Maria Sandovici; Elisabeth Brouwer; Peter Heeringa; Annemieke M H Boots
Journal:  Arthritis Rheumatol       Date:  2021-11-01       Impact factor: 15.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.